Island Pharmaceuticals LtdASX: ILA

Preliminary Final Report

· Issued by Island Pharmaceuticals Ltd via ASX

Filed with ASX ·

Island Pharmaceuticals Limited Appendix 4E Preliminary final report 1 1. Company details Name of entity: Island Pharmaceuticals Limited ABN: 48 641 183 842 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 2. Results for...

View Attachment

6ix hasn’t read this filing yet.

Island Pharmaceuticals Ltd on 6ix

Earlier from Island Pharmaceuticals

Later from Island Pharmaceuticals

All Island Pharmaceuticals news releases